PATENT CLAIM ANALYSIS

Application Number: 16108879
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "250000"]

Abstract:
Methods for treating a subject infected with  Clostridium difficile  comprises administering to the subject a synergistic combination of clofazimine and metronidazole. Pharmaceutical compositions comprising clofazimine and metronidazole are provided for treating  Clostridium difficile  infection and diseases or symptoms associated therewith.

Claim (Index 11):
The method of  claim 10 , wherein the clofazimine analogue is B4129 analogue, B4157 analogue, or B746 analogue.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.35484
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15421982', '15831237', '15576220', '15363523', '14888289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7940339293299171
- 35 USC 102 Novelty (BERT): 0.585865703552638
- Combined Prediction Score: 0.7732171067521892
- Mean Citation Score: 347.448196
- Max Citation Score: 643.03735
- Similarity Product: 373.96645945235184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test